CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Sigma-Aldrich Corporation is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Sigma-Aldrich Corporation
3050 Spruce Street
Phone: (314) 771-5765p:314 771-5765 St. Louis, MO  63103-2530  United States Fax: (302) 674-5266f:302 674-5266

This company was Merged or Acquired on 11/18/2015.
This company ceased filing statements with the SEC on 11/30/2015.
This company is no longer actively traded on any major stock exchange.
This is a Subsidiary, click here for the Parent Company

Business Summary
Sigma-Aldrich Corporation is a life science and high technology company. The Company develops, manufactures, purchases and distributes a range of biochemical and organic chemical products, kits and services that are used in scientific research. It manufactures and distributes around 250,000 chemicals, biochemical and other essential products and approximately 46,000 equipment products. Its business unit structure is aligned into three business units: Research, Applied and SAFC Commercial. Its brands include Sigma-Aldrich, Sigma, Aldrich, Fluka, Riedel-de Haen, Supelco, SAFC, SAFC Biosciences, SAFC Hitech, Genosys, Proligo, Pharmorphix, Cerilliant, Vetec, BioReliance and Cell Marque. It offers its products and services to research and applied labs, pharmaceutical companies, universities, commercial laboratories, industrial companies, biotechnology companies and non-profit organizations, among others. It operates in around 37 countries and sells into approximately 160 countries.
(Source: 10-K)

Scores and Ratings
FRISK®
Score
Z''
Score
PAYCE®
Score
DBT
Index
Moody's
Rating
Fitch
Rating
DBRS
Rating
-Yes-Yes---

Financials, News and Filings
Latest
Statement
Last
Audit

News
SEC
Filings
Bankruptcy
Filings
Suit &
Judgment
Filings
Tax
Lien
Filings
9/30/201512/31/2014YesYes-YesYes

Officers and Directors

Title

Name

Age
Title
Date
Start
Date
Independent Chairman of the Board Barrett A.Toan 67 11/14/2010 11/1/2001
President, Chief Executive Officer, Director RakeshSachdev 59 11/14/2010 11/17/2008
Chief Financial Officer, Executive Vice President Jan A.Bertsch 58 9/15/2013 3/5/2012
12 additional Officers and Directors records available in full report.

Business Names
Business Name
Aldrich Chemical Company, Inc.
Aldrich Chemical Foreign Holding LLC
Aldrich-APL, LLC
95 additional Business Names available in full report.

General Information
Number of Employees: 9,800 (As of 9/30/2015)
Outstanding Shares: 119,992,547 (As of 9/30/2015)
Shareholders: 433
Stock Exchange: NASD
Federal Tax Id: 431050617
Fax Number: (302) 674-5266
Email Address: tdeweese@sial.com


Copyright © 2023 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Tuesday, August 1, 2023